These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8576816)

  • 1. Stated versus actual lipase activity in pancreatic enzyme supplements: implications for clinical use.
    O'Hare MM; McMaster C; Dodge JA
    J Pediatr Gastroenterol Nutr; 1995 Jul; 21(1):59-63. PubMed ID: 8576816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS.
    Maev IV; Kucheryavyy YA; Gubergrits NB; Bonnacker I; Shelest EA; Janssen-van Solingen GP; Domínguez-Muñoz JE
    Drugs R D; 2020 Dec; 20(4):369-376. PubMed ID: 33211277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic enzyme preparations].
    Lamers CB
    Ned Tijdschr Geneeskd; 1987 Oct; 131(40):1750-2. PubMed ID: 3670478
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
    Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipase supplementation therapy: standards, alternatives, and perspectives.
    Layer P; Keller J
    Pancreas; 2003 Jan; 26(1):1-7. PubMed ID: 12499909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
    Layer P; Gröger G
    Digestion; 1993; 54 Suppl 2():10-4. PubMed ID: 7693530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of enzyme substitution in patients with pancreatic insufficiency.
    Worning H
    Scand J Gastroenterol; 1980; 15(5):529-33. PubMed ID: 6160608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of all the lipolytic activities in pancreatin and comparison with porcine and human pancreatic juices.
    Salhi A; Amara S; Mansuelle P; Puppo R; Lebrun R; Gontero B; Aloulou A; Carrière F
    Biochimie; 2020 Feb; 169():106-120. PubMed ID: 31288050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pancreatic exocrine deficiency.
    Sarner M
    World J Surg; 2003 Nov; 27(11):1192-5. PubMed ID: 14534818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme substitution in pancreatic disease.
    Andrén-Sandberg A
    Digestion; 1987; 37 Suppl 1():35-46. PubMed ID: 3650182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exocrine pancreatic insufficiency-like syndrome in giraffe.
    Lechowski R; Pisarski J; Gosławski J; Lenarcik M
    J Wildl Dis; 1991 Oct; 27(4):728-30. PubMed ID: 1721936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease.
    Layer P; Keller J
    J Clin Gastroenterol; 1999 Jan; 28(1):3-10. PubMed ID: 9916657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.